Long-term Safety and Intraocular Pressure Lowering Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: the JUPITER Study

被引：0
|
作者：
Kawase, Kazuhide [1 ]
Vittitow, Jason L. [2 ]
Yamamoto, Tetsuya [1 ]
Araie, Makoto [3 ]
机构：
[1] Gifu Univ Hosp, Gifu, Japan
[2] Bausch Lomb, Clin Affairs, Bridgewater, NJ USA
[3] Kanto Cent Hosp, Mutual Aid Assoc Publ Sch Teachers, Tokyo, Japan
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2016年 / 57卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
3037
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Efficacy of Latanoprostene Bunod Ophthalmic Solution 0.024% Compared With Timolol Maleate Ophthalmic Solution 0.5% in Lowering IOP over 24 hours in Subjects With Open Angle Glaucoma or Ocular Hypertension (CONSTELLATION)
    Liu, John H. K.
    Vittitow, Jason L.
    Ngumah, Quintus
    Weinreb, Robert N.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [22] Latanoprostene Bunod 0.024% Significantly Reduces and Maintains Mean Diurnal Intra-Ocular Pressure (IOP) Compared to Latanoprost 0.005% in Subjects with Open Angle Glaucoma or Ocular Hypertension
    Katz, L. Jay
    Kaufman, Paul
    Ong, Tuyen
    Scassellati-Sforzolini, Baldo
    Vittitow, Jason
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [23] Safety and efficacy of long-term ripasudil 0.4% instillation for the reduction of intraocular pressure in Japanese open-angle glaucoma patients
    Maruyama, Yuko
    Ikeda, Yoko
    Mori, Kazuhiko
    Yoshii, Kengo
    Ueno, Morio
    Yoshikawa, Haruna
    Sotozono, Chie
    Kinoshita, Shigeru
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [24] Safety and Efficacy of Long-Term Ripasudil 0.4% Instillation for the Reduction of Intraocular Pressure in Japanese Open-Angle Glaucoma Patients
    Maruyama, Yuko
    Ikeda, Yoko
    Mori, Kazuhiko
    Yoshii, Kengo
    Ueno, Morio
    Sotozono, Chie
    Kinoshita, Shigeru
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2020, 36 (04) : 229 - 233
  • [25] Long-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucoma and ocular hypertension: year 4
    Williams, R. D.
    Cohen, J. S.
    Gross, R. L.
    Liu, C-c
    Safyan, E.
    Batoosingh, A. L.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2008, 92 (10) : 1387 - 1392
  • [26] Short-term efficacy of latanoprostene bunod for the treatment of open-angle glaucoma and ocular hypertension: a systematic literature review and a network meta-analysis
    Harasymowycz, Paul
    Royer, Catherine
    Cui, Amy Xianying
    Barbeau, Martin
    Jobin-Gervais, Katherine
    Mathurin, Karine
    Lachaine, Jean
    Beauchemin, Catherine
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2022, 106 (05) : 640 - 647
  • [27] Intraocular pressure-lowering efficacy and safety of bimatoprost 0.03% therapy for primary open-angle glaucoma and ocular hypertension patients in China
    Kaidi Wang
    Li Xu
    Zhilan Yuan
    Ke Yao
    Junmei Zhao
    Liang Xu
    Aiwu Fang
    Mingzhi Zhang
    Lingling Wu
    Jian Ji
    Jiamin Hou
    Qing Liu
    Xinghuai Sun
    BMC Ophthalmology, 14
  • [28] Intraocular pressure-lowering efficacy and safety of bimatoprost 0.03% therapy for primary open-angle glaucoma and ocular hypertension patients in China
    Wang, Kaidi
    Xu, Li
    Yuan, Zhilan
    Yao, Ke
    Zhao, Junmei
    Xu, Liang
    Fang, Aiwu
    Zhang, Mingzhi
    Wu, Lingling
    Ji, Jian
    Hou, Jiamin
    Liu, Qing
    Sun, Xinghuai
    BMC OPHTHALMOLOGY, 2014, 14
  • [29] Phase III safety and efficacy study of long-term brinzolamide/timolol fixed combination in Japanese patients with open-angle glaucoma or ocular hypertension
    Nakajima, Masayuki
    Iwasaki, Naoki
    Adachi, Masaki
    CLINICAL OPHTHALMOLOGY, 2014, 8 : 149 - 156
  • [30] The long-term safety and efficacy of brinzolamide 1.0% (Azopt) in patients with primary open-angle glaucoma or ocular hypertension
    March, WF
    Ochsner, KI
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2000, 129 (02) : 136 - 143
12345